PTHS
Pelthos Therapeutics Inc.
+2.36 (+12.15%)21.78USD24.5K成交股數83.4M市值–本益比(近四季)1.9股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 15.6M | 10.9M | 16.5M | 294K | 0 | 0 | – | – | – | – | – | – |
| 營業成本 | 3.6M | 1.7M | 1.7M | 2.3M | 0 | 0 | – | – | – | – | – | – |
| 毛利 | 12.0M | 9.2M | 14.8M | −2.0M | 0 | 0 | – | – | – | – | – | – |
| 毛利率 | 76.9% | 84.7% | 89.9% | -687.8% | – | – | – | – | – | – | – | – |
| 研發費用 | 600K | 186K | 374K | 145K | 515K | 194K | 415K | 13K | 467K | 2.3M | 49K | 50K |
| 銷售管理費用 | 27.7M | 21.1M | 18.5M | 19.6M | 2.7M | 1.6M | 1.6M | 1.2M | 788K | 1.1M | 662K | 538K |
| 營業利益 | −17.3M+436% | −13.1M+614% | −12.0M+486% | −15.4M+771% | −3.2M+67% | −1.8M-53% | −2.0M+59% | −1.8M+127% | −1.9M | −3.9M | −1.3M | −777K |
| 營業利益率 | -111.0% | -120.0% | -72.7% | -5,225.2% | – | – | – | – | – | – | – | – |
| 稅後淨利 | −23.4M+579% | −25.1M+1174% | −21.7M+1178% | −16.2M+816% | −3.4M+35% | −2.0M-51% | −1.7M+19% | −1.8M+86% | −2.6M | −4.0M | −1.4M | −953K |
| 淨利率 | -150.1% | -229.9% | -131.3% | -5,523.1% | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -6.62+25% | -7.57+136% | -9.24+215% | -5.30+73% | -5.29+862% | -3.21 | -2.93 | -3.07 | -0.55 | – | – | – |
| 稀釋股數 | 3.5M | 3.3M | 1.9M | 3.1M | 652K | 613K | 579K | 577K | 4.7M | 1.3M | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 24.2M | 32.0M | 18.0M | 14.2M | 59K | 131K | 1.3M | 2.4M | 3.8M | 100K | 23K | 82K |
| 應收帳款 | 14.5M | 11.7M | 8.9M | – | – | – | – | – | – | – | – | – |
| 存貨 | 21.5M | 23.4M | 23.6M | 24.1M | – | – | – | – | – | – | – | – |
| 總資產 | 137M | 145M | 130M | 126M | 823K | 911K | 2.1M | 2.6M | 4.0M | 96K | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 139M | 126M | 91.5M | 68.2M | 7.3M | 5.1M | 3.6M | 2.8M | 2.9M | 6.5M | – | – |
| 股東權益 | −1.5M | 19.3M | 38.9M | 58.3M | −6.5M | −4.2M | −1.4M | −184K | 1.1M | −6.4M | −5.9M | −4.9M |
| 負債比 | 101.1% | 86.7% | 70.2% | 53.9% | 889.2% | 560.5% | 166.7% | 107.0% | 72.0% | 6,785.8% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −13.1M+1977% | – | – | – | −632K | – | – | −2.0M | – | – | – |
| 資本支出 | – | 194K | – | – | – | 0 | – | – | – | – | – | – |
| 自由現金流 | – | −13.3M+2008% | – | – | – | −632K | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -122.1% | – | – | – | – | – | – | – | – | – | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2026 年度 · 42.3M
| 產品 | 42.3M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 16.8M | – | −43.3M | -257.9% | -23.04 | −22.7M |
| FY2024 | 0 | – | −8.0M | –% | -14.27 | −5.8M |
| FY2023 | – | – | −7.4M | –% | -5.78 | – |
| FY2022 | – | – | −2.5M | –% | – | – |